report-image

Global Ocular Drug Delivery Technology Market Size By Segmentations, Top Key Players, Trend, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 11/23/2022
  • NO OF PAGES
  • 255
  • CATEGORY
  • Information Technology
The competitive landscape analysis of Ocular Drug Delivery Technology Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.

Market estimates and forecast are backed by an extensive primary research, further complemented by on-point secondary research of Ocular Drug Delivery Technology Market. The research analysts have invested significant time and effort in gathering critical industry information from KIPs such as OEMs, top suppliers and distributors, and government bodies.

Market Segmentations:
Global Ocular Drug Delivery Technology Market: Top Key Players
OCULAR THERAPEUTIX
Alimera Sciences
Allergan
EyeGate Pharma
Bausch Health
Envisia Therapeutics
Clearside Biomedical
Graybug Vision
Graybug Vision
Taiwan Liposome Company

Global Ocular Drug Delivery Technology Market: By Types
Topical
Ocular Inserts
Iontophoresis
Intraocular Implants

Global Ocular Drug Delivery Technology Market: By Applications
Hospitals
Ambulatory Surgical Centers
Clinics

Global Ocular Drug Delivery Technology Market: Regions/Countries
North America
Europe
China
Japan
Southeast Asia
India
Central & South America



Global Ocular Drug Delivery Technology Market: Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.

Reasons to Purchase Ocular Drug Delivery Technology Market Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ocular Drug Delivery Technology Revenue
1.4 Market Analysis by Type
1.4.1 Global Ocular Drug Delivery Technology Market Size Growth Rate by Type: 2022 VS 2030
1.4.2 Topical
1.4.3 Ocular Inserts
1.4.4 Iontophoresis
1.4.5 Intraocular Implants
1.5 Market by Application
1.5.1 Global Ocular Drug Delivery Technology Market Share by Application: 2022 VS 2030
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Ocular Drug Delivery Technology Market Perspective (2016-2030)
2.2 Ocular Drug Delivery Technology Growth Trends by Regions
2.2.1 Ocular Drug Delivery Technology Market Size by Regions: 2016 VS 2022 VS 2030
2.2.2 Ocular Drug Delivery Technology Historic Market Share by Regions (2016-2021)
2.2.3 Ocular Drug Delivery Technology Forecasted Market Size by Regions (2022-2030)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ocular Drug Delivery Technology Market Growth Strategy
2.3.6 Primary Interviews with Key Ocular Drug Delivery Technology Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Ocular Drug Delivery Technology Players by Market Size
3.1.1 Global Top Ocular Drug Delivery Technology Players by Revenue (2016-2021)
3.1.2 Global Ocular Drug Delivery Technology Revenue Market Share by Players (2016-2021)
3.1.3 Global Ocular Drug Delivery Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ocular Drug Delivery Technology Market Concentration Ratio
3.2.1 Global Ocular Drug Delivery Technology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ocular Drug Delivery Technology Revenue in 2021
3.3 Ocular Drug Delivery Technology Key Players Head office and Area Served
3.4 Key Players Ocular Drug Delivery Technology Product Solution and Service
3.5 Date of Enter into Ocular Drug Delivery Technology Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2016-2030)
4.1 Global Ocular Drug Delivery Technology Historic Market Size by Type (2016-2021)
4.2 Global Ocular Drug Delivery Technology Forecasted Market Size by Type (2022-2030)

5 Ocular Drug Delivery Technology Breakdown Data by Application (2016-2030)
5.1 Global Ocular Drug Delivery Technology Market Size by Application (2016-2021)
5.2 Global Ocular Drug Delivery Technology Forecasted Market Size by Application (2022-2030)

6 North America
6.1 North America Ocular Drug Delivery Technology Market Size (2016-2021)
6.2 Ocular Drug Delivery Technology Key Players in North America (2016-2021)
6.3 North America Ocular Drug Delivery Technology Market Size by Type (2016-2021)
6.4 North America Ocular Drug Delivery Technology Market Size by Application (2016-2021)

7 Europe
7.1 Europe Ocular Drug Delivery Technology Market Size (2016-2021)
7.2 Ocular Drug Delivery Technology Key Players in Europe (2016-2021)
7.3 Europe Ocular Drug Delivery Technology Market Size by Type (2016-2021)
7.4 Europe Ocular Drug Delivery Technology Market Size by Application (2016-2021)

8 China
8.1 China Ocular Drug Delivery Technology Market Size (2016-2021)
8.2 Ocular Drug Delivery Technology Key Players in China (2016-2021)
8.3 China Ocular Drug Delivery Technology Market Size by Type (2016-2021)
8.4 China Ocular Drug Delivery Technology Market Size by Application (2016-2021)

9 Japan
9.1 Japan Ocular Drug Delivery Technology Market Size (2016-2021)
9.2 Ocular Drug Delivery Technology Key Players in Japan (2016-2021)
9.3 Japan Ocular Drug Delivery Technology Market Size by Type (2016-2021)
9.4 Japan Ocular Drug Delivery Technology Market Size by Application (2016-2021)

10 Southeast Asia
10.1 Southeast Asia Ocular Drug Delivery Technology Market Size (2016-2021)
10.2 Ocular Drug Delivery Technology Key Players in Southeast Asia (2016-2021)
10.3 Southeast Asia Ocular Drug Delivery Technology Market Size by Type (2016-2021)
10.4 Southeast Asia Ocular Drug Delivery Technology Market Size by Application (2016-2021)

11 India
11.1 India Ocular Drug Delivery Technology Market Size (2016-2021)
11.2 Ocular Drug Delivery Technology Key Players in India (2016-2021)
11.3 India Ocular Drug Delivery Technology Market Size by Type (2016-2021)
11.4 India Ocular Drug Delivery Technology Market Size by Application (2016-2021)

12 Central & South America
12.1 Central & South America Ocular Drug Delivery Technology Market Size (2016-2021)
12.2 Ocular Drug Delivery Technology Key Players in Central & South America (2016-2021)
12.3 Central & South America Ocular Drug Delivery Technology Market Size by Type (2016-2021)
12.4 Central & South America Ocular Drug Delivery Technology Market Size by Application (2016-2021)

13 Key Players Profiles
13.1 OCULAR THERAPEUTIX
13.1.1 OCULAR THERAPEUTIX Company Details
13.1.2 OCULAR THERAPEUTIX Business Overview and Its Total Revenue
13.1.3 OCULAR THERAPEUTIX Ocular Drug Delivery Technology Introduction
13.1.4 OCULAR THERAPEUTIX Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.1.5 OCULAR THERAPEUTIX Recent Development
13.2 Alimera Sciences
13.2.1 Alimera Sciences Company Details
13.2.2 Alimera Sciences Business Overview and Its Total Revenue
13.2.3 Alimera Sciences Ocular Drug Delivery Technology Introduction
13.2.4 Alimera Sciences Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.2.5 Alimera Sciences Recent Development
13.3 Allergan
13.3.1 Allergan Company Details
13.3.2 Allergan Business Overview and Its Total Revenue
13.3.3 Allergan Ocular Drug Delivery Technology Introduction
13.3.4 Allergan Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.3.5 Allergan Recent Development
13.4 EyeGate Pharma
13.4.1 EyeGate Pharma Company Details
13.4.2 EyeGate Pharma Business Overview and Its Total Revenue
13.4.3 EyeGate Pharma Ocular Drug Delivery Technology Introduction
13.4.4 EyeGate Pharma Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.4.5 EyeGate Pharma Recent Development
13.5 Bausch Health
13.5.1 Bausch Health Company Details
13.5.2 Bausch Health Business Overview and Its Total Revenue
13.5.3 Bausch Health Ocular Drug Delivery Technology Introduction
13.5.4 Bausch Health Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.5.5 Bausch Health Recent Development
13.6 Envisia Therapeutics
13.6.1 Envisia Therapeutics Company Details
13.6.2 Envisia Therapeutics Business Overview and Its Total Revenue
13.6.3 Envisia Therapeutics Ocular Drug Delivery Technology Introduction
13.6.4 Envisia Therapeutics Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.6.5 Envisia Therapeutics Recent Development
13.7 Clearside Biomedical
13.7.1 Clearside Biomedical Company Details
13.7.2 Clearside Biomedical Business Overview and Its Total Revenue
13.7.3 Clearside Biomedical Ocular Drug Delivery Technology Introduction
13.7.4 Clearside Biomedical Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.7.5 Clearside Biomedical Recent Development
13.8 Graybug Vision
13.8.1 Graybug Vision Company Details
13.8.2 Graybug Vision Business Overview and Its Total Revenue
13.8.3 Graybug Vision Ocular Drug Delivery Technology Introduction
13.8.4 Graybug Vision Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.8.5 Graybug Vision Recent Development
13.9 Graybug Vision
13.9.1 Graybug Vision Company Details
13.9.2 Graybug Vision Business Overview and Its Total Revenue
13.9.3 Graybug Vision Ocular Drug Delivery Technology Introduction
13.9.4 Graybug Vision Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.9.5 Graybug Vision Recent Development
13.10 Taiwan Liposome Company
13.10.1 Taiwan Liposome Company Company Details
13.10.2 Taiwan Liposome Company Business Overview and Its Total Revenue
13.10.3 Taiwan Liposome Company Ocular Drug Delivery Technology Introduction
13.10.4 Taiwan Liposome Company Revenue in Ocular Drug Delivery Technology Business (2016-2021)
13.10.5 Taiwan Liposome Company Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI